David Toung
Stock Analyst
(4.02)
# 3,544
Out of 4,648 analysts
118
Total ratings
60%
Success rate
8.28%
Average return
Main Sectors:
Stocks Rated by David Toung
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ABBV AbbVie | Upgrades: Buy | n/a | $201.98 | - | 6 | Nov 4, 2024 | |
| CAH Cardinal Health | Maintains: Buy | $115 → $125 | $113.35 | +10.28% | 9 | Sep 11, 2024 | |
| UNH UnitedHealth Group | Maintains: Buy | $570 → $600 | $558.85 | +7.36% | 7 | Jul 17, 2024 | |
| CRL Charles River Laboratories International | Downgrades: Hold | n/a | $183.08 | - | 5 | Jun 28, 2024 | |
| AMGN Amgen | Maintains: Buy | $300 → $340 | $317.00 | +7.26% | 10 | Jun 27, 2024 | |
| MCK McKesson | Maintains: Buy | $570 → $670 | $525.59 | +27.48% | 6 | Jun 24, 2024 | |
| ZBH Zimmer Biomet Holdings | Upgrades: Buy | $150 | $107.82 | +39.12% | 7 | May 21, 2024 | |
| LLY Eli Lilly | Maintains: Buy | $770 → $840 | $807.90 | +3.97% | 3 | May 14, 2024 | |
| HOLX Hologic | Maintains: Buy | $89 → $95 | $83.57 | +13.68% | 1 | May 9, 2024 | |
| GEHC GE HealthCare Technologies | Maintains: Buy | $80 → $110 | $86.91 | +26.56% | 1 | Apr 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | n/a | $226.56 | - | 1 | Mar 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $27.84 | - | 1 | Mar 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $253.94 | - | 8 | Mar 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $540 → $550 | $551.78 | -0.32% | 6 | Nov 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $62 | $58.99 | +5.11% | 2 | Sep 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $23.99 | - | 1 | Jun 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $285 → $310 | $365.47 | -15.18% | 2 | May 25, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $285 → $310 | $364.98 | -15.06% | 2 | May 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $265 → $320 | $508.68 | -37.09% | 3 | Dec 22, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $150 → $135 | $118.05 | +14.36% | 4 | Jul 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $75 | $90.48 | -17.11% | 5 | Jan 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $55.15 | - | 4 | Nov 1, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $110 | $101.35 | +8.54% | 3 | Nov 1, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $150 → $165 | $89.59 | +84.17% | 6 | Aug 27, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $8.66 | - | 1 | Aug 2, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $110 → $123 | $76.17 | +60.82% | 3 | Jun 18, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $71.35 | - | 4 | Apr 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $110.50 | - | 3 | Mar 10, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $165 → $155 | $158.73 | -2.35% | 4 | Mar 27, 2020 |
AbbVie
Nov 4, 2024
Upgrades: Buy
Price Target: n/a
Current: $201.98
Upside: -
Cardinal Health
Sep 11, 2024
Maintains: Buy
Price Target: $115 → $125
Current: $113.35
Upside: +10.28%
UnitedHealth Group
Jul 17, 2024
Maintains: Buy
Price Target: $570 → $600
Current: $558.85
Upside: +7.36%
Charles River Laboratories International
Jun 28, 2024
Downgrades: Hold
Price Target: n/a
Current: $183.08
Upside: -
Amgen
Jun 27, 2024
Maintains: Buy
Price Target: $300 → $340
Current: $317.00
Upside: +7.26%
McKesson
Jun 24, 2024
Maintains: Buy
Price Target: $570 → $670
Current: $525.59
Upside: +27.48%
Zimmer Biomet Holdings
May 21, 2024
Upgrades: Buy
Price Target: $150
Current: $107.82
Upside: +39.12%
Eli Lilly
May 14, 2024
Maintains: Buy
Price Target: $770 → $840
Current: $807.90
Upside: +3.97%
Hologic
May 9, 2024
Maintains: Buy
Price Target: $89 → $95
Current: $83.57
Upside: +13.68%
GE HealthCare Technologies
Apr 1, 2024
Maintains: Buy
Price Target: $80 → $110
Current: $86.91
Upside: +26.56%
Mar 25, 2024
Upgrades: Buy
Price Target: n/a
Current: $226.56
Upside: -
Mar 22, 2024
Downgrades: Hold
Price Target: n/a
Current: $27.84
Upside: -
Mar 13, 2024
Downgrades: Hold
Price Target: n/a
Current: $253.94
Upside: -
Nov 6, 2023
Maintains: Buy
Price Target: $540 → $550
Current: $551.78
Upside: -0.32%
Sep 5, 2023
Upgrades: Buy
Price Target: $62
Current: $58.99
Upside: +5.11%
Jun 8, 2023
Downgrades: Hold
Price Target: n/a
Current: $23.99
Upside: -
May 25, 2023
Maintains: Buy
Price Target: $285 → $310
Current: $365.47
Upside: -15.18%
May 10, 2023
Maintains: Buy
Price Target: $285 → $310
Current: $364.98
Upside: -15.06%
Dec 22, 2022
Maintains: Buy
Price Target: $265 → $320
Current: $508.68
Upside: -37.09%
Jul 28, 2022
Maintains: Buy
Price Target: $150 → $135
Current: $118.05
Upside: +14.36%
Jan 28, 2022
Upgrades: Buy
Price Target: $75
Current: $90.48
Upside: -17.11%
Nov 1, 2021
Downgrades: Hold
Price Target: n/a
Current: $55.15
Upside: -
Nov 1, 2021
Upgrades: Buy
Price Target: $110
Current: $101.35
Upside: +8.54%
Aug 27, 2021
Maintains: Buy
Price Target: $150 → $165
Current: $89.59
Upside: +84.17%
Aug 2, 2021
Downgrades: Hold
Price Target: n/a
Current: $8.66
Upside: -
Jun 18, 2021
Maintains: Buy
Price Target: $110 → $123
Current: $76.17
Upside: +60.82%
Apr 12, 2021
Downgrades: Hold
Price Target: n/a
Current: $71.35
Upside: -
Mar 10, 2021
Downgrades: Hold
Price Target: n/a
Current: $110.50
Upside: -
Mar 27, 2020
Reiterates: Buy
Price Target: $165 → $155
Current: $158.73
Upside: -2.35%